World’s Pharmaceutical Inspectorates Prepare For Post-Pandemic Remote Site Assessments
US, EU, global authorities share experiences, insights, advice for industry on remote alternatives even after inspectors can resume travels.
You may also be interested in...
Time taken for interagency alignment, lessons learned from foreign counterparts will increase use of remote video tours, FDA officials tell the Pink Sheet.
Video facility tours expected to help clear way for timely drug and biologic approvals while COVID-19 still prevents inspections.
Contract development and manufacturing organization relied on combination of immersive mixed-reality devices to host remote inspection.